[Federal Register Volume 64, Number 191 (Monday, October 4, 1999)]
[Notices]
[Pages 53680-53681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-25683]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-99-43]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506 (c) (2) (A) of
the Paperwork reduction Act of 1995, the Center for Disease Control and
Prevention is providing opportunity for public comment on proposed data
collection projects. To request more information on the proposed
projects or to obtain a copy of the data collection plans and
instruments, call the CDC Reports Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) The accuracy of the agency's estimate of the burden of the
[[Page 53681]]
proposed collection of information; (c) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) Ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24,
Atlanta, GA 30333. Written comments should be received within 60 days
of this notice.
Proposed Projects
Multi-Center Cohort Study to Assess the Risk and Consequences of
Hepatitis C Virus Transmission from Mother to Infant (0920-0344)--
Renewal--The National Center for Infectious Diseases (NCID)--The
purpose of the proposed study is (1) To determine the incidence of
vertical hepatitis C virus (HCV) transmission, (2) To assess risk
factors for vertical HCV transmission, (3) To assess the clinical
course of disease among infants with HCV infection, and (4) To assess
diagnostic methods for detecting HCV infection in infants. HCV is a
blood-borne pathogen and is the major etiologic agent of what was
previously referred to as parenterally-transmitted non-A, non-B
hepatitis. Diagnostic tests for HCV infection have recently been
developed and HCV has been demonstrated to account for about 20% of all
cases of viral hepatitis in the United States. Virtually all adults
with acute HCV infection may become chronically infected and 50%-60%
may develop chronic liver disease with persistently elevated liver
enzymes. Of adults with chronic liver disease, 30%-60% may develop
chronic active hepatitis and 5%-20% may develop cirrhosis within five
years after illness onset. HCV is also a major contributing cause of
hepatocellular carcinoma. An estimated 8,000-10,000 chronic liver
disease deaths per year in the United States are attributable to HCV
infection. There are no costs to respondents other than their time to
participate.
----------------------------------------------------------------------------------------------------------------
Burden hours
Form name No. of No. responses per Total burden
respondents per respondent respondent hours
----------------------------------------------------------------------------------------------------------------
Form A.......................................... 300 1 0.25 75
Form B.......................................... 1200 1 0.25 300
Form C.......................................... 300 1 0.10 30
Form E.......................................... 300 1 0.25 75
Form G.......................................... 300 8 0.10 240
---------------------------------------------------------------
Total....................................... .............. .............. .............. 720
----------------------------------------------------------------------------------------------------------------
2. Chronic Fatigue Syndrome (CFS) Surveillance and Related Studies,
Prevalence and Incidence of Fatiguing Illness in Sedgewick County,
Kansas (0920-0401)--Renewal--The National Center for Infectious
Diseases (NCID)--A Population-Based CFS Study was done previously in
Kansas in 1997. Data from this cross-sectional, random-digit-dial
survey of prolonged fatiguing illness in Wichita, Kansas will be added
to the data previously obtained during the past 24-months from this
population.
The proposed study continues the Sedgwick County study using
identical methodology and data collection instruments. Beginning with a
random-digit-dial telephone survey to identify previously identified
fatigued and non-fatigued individuals, followed by a detailed telephone
interview to obtain additional data on participants' health status
during the last 12-month period. Study objectives remain to refine
estimates of CFS in Wichita, identify similarities and differences
among fatigued and non-fatigued subjects and to describe the clinical
course of fatiguing illness in this population.
----------------------------------------------------------------------------------------------------------------
No. of Average burden/
Respondents No. of responses/ respondent Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Individuals screened............................ 4,500 1 0.083 374
Individuals interviewed......................... 4,500 1 0.25 1,125
---------------------------------------------------------------
Total....................................... .............. .............. .............. 1,499
----------------------------------------------------------------------------------------------------------------
Nancy Cheal,
Acting Associate Director for Policy, Planning, and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 99-25683 Filed 10-1-99; 8:45 am]
BILLING CODE 4163-18-P
